Cytophage Technologies Inc.
$0.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- August 1, 2025 – December 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q2-1032885
Published purpose
This project will advance Cytophage’s Quality Assurance and Quality Control (QA/QC) systems and optimize manufacturing processes for its first bacteriophage-based animal health product. By addressing the unique production challenges of phage biologics, the project will enable GMP-certified manufacturing and support regulatory approval and commercialization of this innovative alternative to antibiotics in animal agriculture.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 17, 2026 from open.canada.ca Grants & Contributions